Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

Abroad (travel likely)Recruiting

Conditions

Multiple Sclerosis · Clinically Isolated Syndrome · NMOSD · Myasthenia Gravis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California-San Francisco, San Francisco, California, United States
Contact: Study coordinator (Min Ji Kim) · minji.kim3@ucsf.edu · 415-502-7209
Contact: Study coordinator (Ayushi Balan) · ayushi.balan@ucsf.edu · 415-514-8330
Contact: Principal Investigator (Riley Bove)

Study leads

Riley Bove, MD, MSc
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

China National Registry of Neuro-Inflammatory Diseases

Multiple Sclerosis · NMO Spectrum Disorder · Clinically Isolated Syndrome

Abroad (travel likely)Recruiting

Beijing, China

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (RRMS) · Anti-CD20 Therapy

Abroad (travel likely)RecruitingPHASE3

Montpellier, France

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

Progressive Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Kogarah, Australia · New Lambton Heights, Australia

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE4

New Haven, United States · Washington D.C., United States